Anti-inflammatory roles of mesenchymal stromal cells during acute Streptococcus pneumoniae pulmonary infection in mice

作者：Asami Takahiro; Ishii Makoto^*; Namkoong Ho; Yagi Kazuma; Tasaka Sadatomo; Asakura Takanori; Suzuki Shoji; Kamo Tetsuro; Okamori Satoshi; Kamata Hirofumi; Zhang Haiyue; Hegab Ahmed E; Hasegawa Naoki; Betsuyaku Tomoko

来源：Cytotherapy, 2018, 20(3): 302-313.

DOI：10.1016/j.jcyt.2018.01.003

• cell therapy
• mesenchymal stromal cells
• pneumonia
• Streptococcus pneumoniae

Background. Pneumonia is the fourth leading cause of death worldwide, and Streptococcus pneumoniae is the most commonly associated pathogen. Increasing evidence suggests that mesenchymal stromal cells (MSCs) have anti-inflammatory roles during innate immune responses such as sepsis. However, little is known about the effect of MSCs on pneumococcal pneumonia. Methods. Bone marrow-derived macrophages (BMDMs) were stimulated with various ligands in the presence or absence of MSC-conditioned medium. For in vivo studies, mice intranasally-inoculated with S. pneumoniae were intravenously treated with MSCs or vehicle, and various parameters were assessed. Results. After stimulation with toll-like receptor (TLR) 2, TLR9 or TLR4 ligands, or live S. pneumoniae, TNF-alpha and interleukin (IL)-6 levels were significantly decreased, whereas IL-10 was significantly increased in BMDMs cultured in MSC-conditioned medium. In mice, MSC treatment decreased the number of neutrophils in bronchoalveolar lavage fluid (BALF) after pneumococcal infection, and this was associated with a decrease in myeloperoxidase activity in the lungs. Levels of proinflammatory cytokines, includingTNF-alpha, IL-6, GMCSF and IFN-gamma, were significantly lower in MSC-treated mice, and the bacterial load in the lung after pneumococcal infection was significantly reduced. In addition, histopathologic analysis confirmed a decrease in the number of cells recruited to the lungs; however, lung edema, protein leakage into the BALF and levels of the antibacterial protein lipocalin 2 in the BALF were comparable between the groups. Conclusions. These results indicate that MSCs could represent a potential therapeutic application for the treatment of pneumonia caused by S. pneumoniae.

• 出版日期2018-3